Neurofibromatosis Type 2 Gene Therapy
Research on neurofibromatosis type 2 gene therapy described by scientists at Mayo Clinic, Department of Otorhinolaryngology
Published in Gene Therapy Weekly, March 4th, 2010
Scientists discuss in 'Radiation-induced rhabdomyosarcoma of the brainstem in a patient with neurofibromatosis type 2' new findings in neurofibromatosis type 2. "Neurofibromatosis Type 2 (NF2) is a rare autosomal dominant disorder characterized by the development of benign tumors of the peripheral nervous system and the CNS, including schwannomas, meningiomas, and ependymomas. The gene responsible for the development of NF2 acts as a tumor suppressor gene," investigators in the United States report.
"Stereotactic radiotherapy (SRT) or single-fraction stereotactic radiosurgery has been increasingly used in the past decades to treat benign tumors in patients with NF2....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2010-03-04)
More Articles from Gene Therapy Weekly
- Research
A common thread links multiple human cognitive disorders - Adenovirus
Findings from Y. Kato and co-authors broaden understanding of adenovirus - Breast Cancer
Recent findings from Human Genome Center highlight research in breast cancer - Emphysema
Researchers from Boston University detail findings in emphysema - Endometriosis
Investigators at University of Bari have published new data on endometriosis - Gene Therapy
New data from University of Alberta illuminate research in gene therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
